Results
|
|
2161.
|
|
|
|
2162.
|
|
|
|
2163.
|
|
|
|
2164.
|
|
|
|
2165.
|
|
|
|
2166.
|
|
|
|
2167.
|
|
|
|
2168.
|
|
|
|
2169.
|
|
|
|
2170.
|
|
|
|
2171.
|
|
|
|
2172.
|
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial. [electronic resource] by
- Atsumi, Tatsuya
- Tanaka, Yoshiya
- Yamamoto, Kazuhiko
- Takeuchi, Tsutomu
- Yamanaka, Hisashi
- Ishiguro, Naoki
- Eguchi, Katsumi
- Watanabe, Akira
- Origasa, Hideki
- Yasuda, Shinsuke
- Yamanishi, Yuji
- Kita, Yasuhiko
- Matsubara, Tsukasa
- Iwamoto, Masahiro
- Shoji, Toshiharu
- Togo, Osamu
- Okada, Toshiyuki
- van der Heijde, Désirée
- Miyasaka, Nobuyuki
- Koike, Takao
Producer: 20170821
In:
Annals of the rheumatic diseases vol. 76
Availability: No items available.
|
|
|
2173.
|
|
|
|
2174.
|
|
|
|
2175.
|
|
|
|
2176.
|
|
|
|
2177.
|
|
|
|
2178.
|
|
|
|
2179.
|
|
|
|
2180.
|
|